Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysis
Amit Roy, Randall J Brenneman, Jacob Hogan, Justin M Barnes, Yi Huang, Robert Morris, Sreekrishna Goddu, Michael Altman, Jose Garcia-Ramirez, Harold Li, others
January, 2021